Finch Therapeutics Group analyst ratings
Finch Therapeutics Group analyst ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/09/2022 | 605.39% | HC Wainwright & Co. | → $17 | Initiates Coverage On | → Buy |
| 04/04/2022 | 605.39% | Jefferies | $29 → $17 | Maintains | Buy |
| 04/13/2021 | 1310.79% | Evercore ISI Group | → $34 | Initiates Coverage On | → Outperform |
| 04/13/2021 | 1103.32% | Jefferies | → $29 | Initiates Coverage On | → Buy |
| 04/13/2021 | 937.34% | B of A Securities | → $25 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/09/2022 | 605.39% | HC Wainwright & Co. | → 17 美元 | 启动覆盖范围开启 | → 购买 |
| 2022 年 4 月 4 日 | 605.39% | 杰富瑞集团 | 29 美元 → 17 美元 | 维护 | 买 |
| 04/13/2021 | 1310.79% | Evercore ISI 集团 | → 34 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 04/13/2021 | 1103.32% | 杰富瑞集团 | → 29 美元 | 启动覆盖范围开启 | → 购买 |
| 04/13/2021 | 937.34% | B of A 类证券 | → 25 美元 | 启动覆盖范围开启 | → 购买 |
Finch Therapeutics Group Questions & Answers
芬奇疗法集团问题与解答
The latest price target for Finch Therapeutics Group (NASDAQ: FNCH) was reported by HC Wainwright & Co. on August 9, 2022. The analyst firm set a price target for $17.00 expecting FNCH to rise to within 12 months (a possible 605.39% upside). 2 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2022年8月9日公布了芬奇疗法集团（纳斯达克股票代码：FNCH）的最新目标股价。该分析公司将目标股价定为17.00美元，预计FNCH将在12个月内升至12个月内（可能上涨605.39％）。去年有两家分析公司公布了评级。
The latest analyst rating for Finch Therapeutics Group (NASDAQ: FNCH) was provided by HC Wainwright & Co., and Finch Therapeutics Group initiated their buy rating.
Finch Therapeutics Group（纳斯达克股票代码：FNCH）的最新分析师评级由HC Wainwright & Co. 提供，Finch Therapeutics Group启动了买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Finch Therapeutics Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Finch Therapeutics Group was filed on August 9, 2022 so you should expect the next rating to be made available sometime around August 9, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Finch Therapeutics Group的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。Finch Therapeutics Group的最新评级是在2022年8月9日发布的，因此您应该预计下一个评级将在2023年8月9日左右公布。
While ratings are subjective and will change, the latest Finch Therapeutics Group (FNCH) rating was a initiated with a price target of $0.00 to $17.00. The current price Finch Therapeutics Group (FNCH) is trading at is $2.41, which is within the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但Finch Therapeutics Group（FNCH）的最新评级是首次提出，目标股价为0.00美元至17.00美元。Finch Therapeutics Group（FNCH）目前的交易价格为2.41美元，在分析师的预测区间内。